Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced an update on their stock buy-back program, revealing the purchase of 3,500 shares on the previous day, adding to the 52,690 shares bought back before that. The update, part of a routine notification to the market, indicates the company’s ongoing efforts to repurchase its ordinary fully paid shares under the buy-back scheme.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
